Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker

Published:2021-03-30 Issue:5 Volume:89 Page:895-910
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Annals of Neurology

Author:

Aktas Orhan¹^ORCID,Smith Michael A.²^ORCID,Rees William A.²^ORCID,Bennett Jeffrey L.³^ORCID,She Dewei²,Katz Eliezer²,Cree Bruce A. C.⁴^ORCID,Fujihara Kazuo,Paul Friedemann,Hartung Hans‐Peter,Marignier Romain,Kim Ho Jin,Weinshenker Brian G.,Pittock Sean J.,Wingerchuk Dean M.,Cutter Gary R.,Green Ari J.,Mealy Maureen A.,Drappa Jorn,

Affiliation:

1. Medical Faculty Heinrich Heine University Düsseldorf Germany

2. Viela Bio Gaithersburg MD

3. School of Medicine, Anschutz Medical Campus University of Colorado Aurora CO

4. Department of Neurology UCSF Weill Institute for Neurosciences, University of California San Francisco San Francisco CA

Funder

MedImmune

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26067

Reference46 articles.

1. Placebo-controlled study in neuromyelitis optica—Ethical and design considerations

2. Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

3. An open label study of the effects of rituximab in neuromyelitis optica

4. Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders

5. Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapse-Independent disease activity in neuromyelitis optica spectrum disorder: A systematic review;Multiple Sclerosis and Related Disorders;2024-10

2. NMOSD and MOGAD: an evolving disease spectrum;Nature Reviews Neurology;2024-09-13

3. Is there a prodrome to NMOSD? An investigation of neurologic symptoms preceding the first NMOSD attack;Multiple Sclerosis Journal;2024-09-11

4. Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGAD;Multiple Sclerosis Journal;2024-09-05

5. B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity;Annals of Clinical and Translational Neurology;2024-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3